185 related articles for article (PubMed ID: 6376684)
1. Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin.
Potter TA; Boyer C; Verhulst AM; Golstein P; Rajan TV
J Exp Med; 1984 Jul; 160(1):317-22. PubMed ID: 6376684
[TBL] [Abstract][Full Text] [Related]
2. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice.
Pascolo S; Bervas N; Ure JM; Smith AG; Lemonnier FA; Pérarnau B
J Exp Med; 1997 Jun; 185(12):2043-51. PubMed ID: 9182675
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Db-restricted SV40-specific CTL-mediated lysis.
Tanaka Y; Tevethia SS
Virology; 1988 Aug; 165(2):357-66. PubMed ID: 2970152
[TBL] [Abstract][Full Text] [Related]
4. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
[TBL] [Abstract][Full Text] [Related]
5. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of an EL4 cell line that expresses H-2Db but not H-2Kb or beta 2-microglobulin.
Potter TA; Zeff RA; Schmitt-Verhulst AM; Rajan TV
Proc Natl Acad Sci U S A; 1985 May; 82(9):2950-4. PubMed ID: 3887412
[TBL] [Abstract][Full Text] [Related]
7. Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.
Milisauskas VK; Kaminsky SG; Nakamura I
Eur J Immunol; 1987 Jul; 17(7):1043-9. PubMed ID: 2440692
[TBL] [Abstract][Full Text] [Related]
8. MHC class I phenotype and function of human beta 2-microglobulin transgenic murine lymphocytes.
Bjerager L; Pedersen LO; Bregenholt S; Nissen MH; Claesson MH
Scand J Immunol; 1996 Dec; 44(6):615-22. PubMed ID: 8972744
[TBL] [Abstract][Full Text] [Related]
9. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
[TBL] [Abstract][Full Text] [Related]
10. Differential reactivity of residual CD8+ T lymphocytes in TAP1 and beta 2-microglobulin mutant mice.
Ljunggren HG; Van Kaer L; Ashton-Rickardt PG; Tonegawa S; Ploegh HL
Eur J Immunol; 1995 Jan; 25(1):174-8. PubMed ID: 7843229
[TBL] [Abstract][Full Text] [Related]
11. A role for helper cell subpopulations in a genetically controlled cytolytic T lymphocyte response to the H-2Db antigen.
French DL; Plate JM
J Immunol; 1985 Jul; 135(1):39-46. PubMed ID: 3158704
[TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db.
Allen H; Fraser J; Flyer D; Calvin S; Flavell R
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7447-51. PubMed ID: 3532114
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an Lyt-2+ alloreactive cytotoxic T cell clone specific for H-2Db that cross-reacts with I-Ek.
Schilham MW; Lang R; Benner R; Zinkernagel RM; Hengartner H
J Immunol; 1986 Nov; 137(9):2748-54. PubMed ID: 3489776
[TBL] [Abstract][Full Text] [Related]
14. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
Smyth MJ; Snook MB
Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
[TBL] [Abstract][Full Text] [Related]
15. Rejuvenated expression of H-2Kb in RMA-S cells does not affect alloreactive T cell- and natural killer cell-mediated lysis.
Kesari KV; Geliebter J
Immunol Lett; 1993 Sep; 38(1):77-83. PubMed ID: 8300157
[TBL] [Abstract][Full Text] [Related]
16. Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.
Ohlén C; Bastin J; Ljunggren HG; Foster L; Wolpert E; Klein G; Townsend AR; Kärre K
J Immunol; 1990 Jul; 145(1):52-8. PubMed ID: 2358681
[TBL] [Abstract][Full Text] [Related]
17. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
Altevogt P; Leidig S; Heckl-Oestreicher B
Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
[TBL] [Abstract][Full Text] [Related]
18. The MHC-encoded class I molecule, H-2Kk, demonstrates distinct requirements of assembly factors for cell surface expression: roles of TAP, Tapasin and beta2-microglobulin.
Prasanna SJ; Nandi D
Mol Immunol; 2004 Aug; 41(10):1029-45. PubMed ID: 15302165
[TBL] [Abstract][Full Text] [Related]
19. Allospecific cytolytic T lymphocytes recognize conformational determinants on hybrid mouse transplantation antigens.
Bluestone JA; Foo M; Allen H; Segal D; Flavell RA
J Exp Med; 1985 Jul; 162(1):268-81. PubMed ID: 2409207
[TBL] [Abstract][Full Text] [Related]
20. Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes.
Blake J; Johnston JV; Hellström KE; Marquardt H; Chen L
J Exp Med; 1996 Jul; 184(1):121-30. PubMed ID: 8691125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
